1. Ahuja V, Coleman RE, Herndon J, Patz EF (1998) Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. Cancer 83:918–924
2. Amano S, Inoue T, Tomiyoshi K et al (1998) In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer. J Nucl Med 39:1424–1427
3. Bassa P, Kim EE, Inoue T, Wong FC, Korkmaz M, Yang DJ, Hicks KW, Buzdar AU, Podoloff DA (1996) Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. J Nucl Med 37:931–938
4. Bauer C, Bauder-Wuest U, Mier W, Haberkorn U, Eisenhut M (2005) 131I-labeled peptides as caspase substrates for apoptosis imaging. J Nucl Med 46:1066–1074
5. Bergstrom M, Collins VP, Ehrin E et al (1983) Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 7:1062–1066